Literature DB >> 22059727

Protein C, protein S and von Willebrand factor levels correlate with bleeding symptoms: a population-based study.

P Rojnuckarin1, N Uaprasert, B Akkawat, R Settapiboon, T Nanakorn, T Intragumtornchai.   

Abstract

Although natural anticoagulant deficiencies are the established causes of thrombosis, their roles in bleeding are not fully studied. The objective is to correlate haemostatic factors with haemorrhagic symptoms quantified by a standardized questionnaire. Adult subjects were recruited from Bangkok and nearby provinces as part of routine health surveys/checkups. The validated MCMDM-1VWD form was used to assess their bleeding symptoms. At the same time, von Willebrand factor (VWF) activity, free protein S levels and protein C activity were measured. There were 5196 individuals. The mean age was 44.3 years (range 15-99) and 41% were male subjects. The mean bleeding score was -0.28 and 95% of subjects had scores between -2 and +2. The scores were lower in female subjects than in male subjects (-0.35 vs. -0.16, P < 0.001). Bleeding scores correlated negatively with age, VWF and protein C activities (Spearman's ρ-0.258, -0.091 and -0.098, respectively, all P < 0.001), but did not significantly correlate with protein S levels. Using multivariate analysis, female gender, VWF below 100 IU dL(-1), protein C below 100 IU dL(-1) and protein S over 150 IU dL(-1) significantly related to high (≥3) bleeding scores (adjusted odds ratio 1.95, 1.83, 1.56 and 2.84, P = 0.001, 0.001, 0.039 and 0.017, respectively). These findings may suggest interacting roles of VWF and natural anticoagulants in modifying bleeding symptoms.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22059727     DOI: 10.1111/j.1365-2516.2011.02678.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

1.  Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center.

Authors:  Chatphatai Moonla; Benjaporn Akkawat; Yaowaree Kittikalayawong; Autcharaporn Sukperm; Mukmanee Meesanun; Noppacharn Uaprasert; Darintr Sosothikul; Ponlapat Rojnuckarin
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

2.  Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.

Authors:  Avirup Guha; Cesar Caraballo; Prantesh Jain; P Elliott Miller; Jocelyn Owusu-Guha; Katherine A A Clark; Eric J Velazquez; Tariq Ahmad; Lauren A Baldassarre; Daniel Addison; Neal L Weintraub; Nihar R Desai
Journal:  ESC Heart Fail       Date:  2021-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.